Pharma Focus Asia

Webinar Sponsored byPRMA Consulting

PRMA Consulting

14th September 2020


Duration: 30 minutes

08:15 BST | 16:00 BST

Jan McKendrick

Jan McKendrick

Senior Director

Transform your market access in Asia-Pacific: a free virtual event

The Asia-Pacific region is critical to the future growth plans of pharmaceutical manufacturers and PRMA Consulting are leading ground-breaking market access projects in the region.

Please join our virtual event “Transform your market access in Asia-Pacific” on September 14 when regional market access experts will offer recommendations for:

  • Assessing market access and commercialization risks, opportunities, and evidence needs for products in Asia-Pacific markets
  • Improving early planning and cross-functional alignment on local implementation of development programs
  • Developing forward-looking integrated evidence generation plans that cover different Asia‑Pacific payer needs
  • Leveraging digital tools to transform value and access outcomes in the Asia-Pacific region.

We will also be celebrating the opening of our new office in Singapore, an important step towards realizing improved market access for manufacturers with an interest in the region.

Register your interest for this free event, grab a coffee, and join the conversation.

Why you should register today:

  • Unique insight: Share our market access expertise with your team
  • FREE recording: Watch the on-demand session at your convenience
  • FREE eBook: Read how a leading manufacturer drove optimal market access for their products in the Asia-Pacific region
**Under no circumstances we will share or sell your email and contact information with any govt or private entity.

About - Jan McKendrick

Jan has more than 25 years’ experience in the pharmaceutical industry, including 4 years as a clinical trial statistician and 11 years in health outcomes at Eli Lilly in the UK. Jan played a key role in developing the strategy for engaging with NICE in its early days, and has extensive experience in developing HTA submissions.

At PRMA Consulting, Jan leads and provides strategic input into projects to develop the evidence base to support the value of products, including translating that information into supporting HTA submissions. She is responsible for setting the vision for the PRMA Healthcheck® digital application, which has been used to determine evidence generation strategies to support optimal market access outcomes, predominantly in Europe but also in the US and Asia-Pacific regions.